Researchers' views of the acceptability of restrictive provisions in clinical trial agreements with industry sponsors

Accountability in Research
Michelle M MelloDavid M Studdert

Abstract

We conducted a mail survey of 884 U.S. medical school faculty active in clinical research to elicit their views about the acceptability of provisions in contracts for industry-sponsored clinical trials that would restrict investigators' academic freedom and control over trials. We compared their responses to results from a similar survey of research administrators at 107 medical schools. There was substantial variation among clinical researchers in their acceptability judgments, with a relatively large proportion of clinical trial investigators willing to accept provisions that give industry sponsors considerable control over the dissemination of research results. There were significant differences in the perceptions of clinical trial investigators versus other recently published clinical researchers; investigators with a high versus low percentage of research support from industry; junior versus senior faculty; and investigators at institutions with high versus low National Institute of Health (NIH) funding ranks. There was also a significant divergence of views in a number of areas between clinical trialists and research administrators who negotiate clinical trial contracts on their behalf. Medical school faculty could benefi...Continue Reading

References

Feb 8, 1996·The New England Journal of Medicine·D BlumenthalK S Louis
Jan 1, 1996·International Journal of Technology Assessment in Health Care·L A Bero, D Rennie
Dec 5, 1996·The New England Journal of Medicine·D BlumenthalK S Louis
Jan 10, 1998·JAMA : the Journal of the American Medical Association·S G KorenmanV Lew
May 18, 2000·The New England Journal of Medicine·M Angell
May 18, 2000·The New England Journal of Medicine·T Bodenheimer
Nov 1, 2000·JAMA : the Journal of the American Medical Association·M K ChoD Rennie
Nov 1, 2000·JAMA : the Journal of the American Medical Association·E A Boyd, L A Bero
Nov 30, 2000·The New England Journal of Medicine·B LoA Berkeley
Nov 30, 2000·The New England Journal of Medicine·J B Martin, D L Kasper
Mar 29, 2001·Science and Engineering Ethics·R A BerkN S Wenger
Oct 25, 2002·The New England Journal of Medicine·Kevin A SchulmanRobert M Califf
Oct 25, 2002·The New England Journal of Medicine·Jeffrey M Drazen
Oct 25, 2002·The New England Journal of Medicine·David G Nathan, David J Weatherall
Jan 22, 2003·JAMA : the Journal of the American Medical Association·Justin E BekelmanCary P Gross
Mar 21, 2003·Science and Engineering Ethics·Nancy F Olivieri
Mar 21, 2003·Science and Engineering Ethics·David Weatherall
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Aug 14, 2003·Academic Medicine : Journal of the Association of American Medical Colleges·Elizabeth A BoydLisa A Bero
Dec 19, 2003·The New England Journal of Medicine·David Blumenthal
Feb 12, 2004·Journal of Medical Ethics·G DuVal
Jan 29, 2005·Accountability in Research·Shira LiptonLisa A Bero
May 27, 2005·The New England Journal of Medicine·Michelle M MelloDavid M Studdert

❮ Previous
Next ❯

Citations

Nov 13, 2008·The American Journal of Bioethics : AJOB·Inmaculada de Melo-Martin
Aug 2, 2008·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J D Schold, B Kaplan
Jul 21, 2015·Accountability in Research·Serina StrettonKaren L Woolley
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark Parascandola
Jan 30, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Inmaculada de Melo-Martín, Kristen Intemann
Jun 29, 2007·The New England Journal of Medicine·Michelle M Mello, Steven Joffe

❮ Previous
Next ❯

Software Mentioned

MEDLINE
SPSS
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.